Companies / Pfizer
Pfizer
PFE United States
ID 24 · CIK 78003 · reconciled 2026-10-10T16:39
SEC EDGAR filings ↗ Raw model extractions
Employees (legacy)
Revenue FY2025
62.6B
▼ 1.6% vs FY2024
Net profit FY2025
7.8B
▼ 3.1% vs FY2024
Total assets FY2025
208.2B
▼ 2.5% vs FY2024
Stockholders' equity FY2025
86.5B
▼ 2.0% vs FY2024
Operating cash flow FY2025
11.7B
▼ 8.2% vs FY2024
EPS (diluted) FY2025
1.36
▼ 3.5% vs FY2024
Employees FY2025
75,000
▼ 7.4% vs FY2024
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
All entities
Segment data comes from F4: entity names are clustered across models with Qwen, then each period is a majority vote.
Unlike F1–F3 there is no 2-model minimum — hover a value to see how many models reported it.
Vote results
| Source | Validated | Discarded | Calculated | Empty | Discard rate |
|---|---|---|---|---|---|
| F1 · income statement | 1,599 | 67 | 389 | 323 | 4.0% |
| F2 · balance sheet | 2,970 | 119 | 0 | 631 | 3.9% |
| F3 · cash flow | 629 | 16 | 887 | 161 | 2.5% |
| F5 · human capital | 74 | 0 | 0 | 391 | 0.0% |
Re-run plan for this company
| Action | Source | Form | Period end | Accession | Tier | Fields | Missing models |
|---|---|---|---|---|---|---|---|
| run third ai | F1 | 10-Q | 1995-10-01 | 0000078003-95-000007 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1996-03-31 | 0000078003-96-000003 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1996-06-30 | 0000078003-96-000008 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1996-09-29 | 0000078003-96-000011 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-03-30 | 0000078003-97-000002 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-06-29 | 0000078003-97-000005 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-09-28 | 0000078003-97-000015 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1999-10-03 | 0000078003-99-000042 | 3 | revenue[ytd] | no-ai-xblr |
| run third ai | F2 | 10-K | 2001-12-31 | 0000950123-02-003116 | 2 | total_liabilities | no-ai-xblr |
| run third ai | F2 | 10-Q | 1999-07-04 | 0000078003-99-000024 | 3 | total_stockholders_equity | no-ai-xblr |
| run third ai | F2 | 10-Q | 1999-10-03 | 0000078003-99-000042 | 3 | total_liabilities, total_stockholders_equity | no-ai-xblr |